Showing 15,181 - 15,200 results of 15,382 for search '"Plasmodium"', query time: 0.21s Refine Results
  1. 15181
  2. 15182

    Comparing the Infection Biology of Plasmodiophora brassicae in Clubroot Susceptible and Resistant Hosts and Non-hosts by Lijiang Liu, Lijiang Liu, Li Qin, Xiaohui Cheng, Yi Zhang, Li Xu, Fan Liu, Chaobo Tong, Junyan Huang, Shengyi Liu, Yangdou Wei

    Published 2020-10-01
    “…However, during the secondary infection phase, no secondary plasmodium was detected in the cortical cells of both resistant hosts in contrast to massive secondary plasmodia present in the cortex tissue of two susceptible hosts leading to root swelling at 15 dpi. …”
    Get full text
    Article
  3. 15183

    Interactions between 4-aminoquinoline and heme: Promising mechanism against Trypanosoma cruzi by Guilherme Curty Lechuga, Júlio Cesar Borges, Claudia Magalhães Calvet, Humberto Pinheiro de Araújo, Aline Araujo Zuma, Samara Braga do Nascimento, Maria Cristina Machado Motta, Alice Maria Rolim Bernardino, Mirian Claudia de Souza Pereira, Saulo Cabral Bourguignon

    Published 2016-12-01
    “…The potency of 1g in combination with heme was enhanced against epimastigotes and trypomastigotes, suggesting a similar mechanism of action that occurs in Plasmodium spp. The addition of hemin to the culture medium increased trypanocidal activity of analog 1g without changing the cytotoxicity of the host cell, reaching an IC50 of 11.7 μM for trypomastigotes. …”
    Get full text
    Article
  4. 15184

    Transcriptional variation in Babesia gibsoni (Wuhan isolate) between in vivo and in vitro cultures in blood stage by Zhen Han, Yaxin Zheng, Yu Shi, Fangwei Chen, Chenglong Wu, Lingna Wang, Shiyu Lu, Dongfang Li, Xingai Guan, Lan He, Junlong Zhao

    Published 2023-08-01
    “…The development of in vitro culture technology has driven research progress in various kinds of omics studies, including transcriptomic analysis of Plasmodium spp. between in vitro and in vivo environments, which has prompted the observation of diagnostic antigens and vaccine development. …”
    Get full text
    Article
  5. 15185
  6. 15186

    Lactate clearance as a prognostic marker of mortality in severely ill febrile children in East Africa by A. Aramburo, Jim Todd, Elizabeth C. George, Sarah Kiguli, Peter Olupot-Olupot, Robert O. Opoka, Charles Engoru, Samuel O. Akech, Richard Nyeko, George Mtove, Diana M. Gibb, Abdel G. Babiker, Kathryn Maitland

    Published 2018-03-01
    “…Results Of 3170 children in the FEAST trial, including 1719 children (57%) with Plasmodium falciparum malaria, 3008 (95%) had a baseline lactate measurement, 2127 (71%) had HL (lactate ≥ 2.5 mmol/L), and 1179 (39%) had severe HL (≥ 5 mmol/L). …”
    Get full text
    Article
  7. 15187
  8. 15188

    Anti-malarial activity of HCl salt of SKM13 (SKM13-2HCl) by Thuy-Tien Thi Trinh, Su-Yeon Yun, Gum-Ju Bae, Kwonmo Moon, Hyelee Hong, Tae Hui Eum, Young-ah Kim, Soon-Ai Kim, Hyun Park, Hak Sung Kim, Seon-Ju Yeo

    Published 2022-12-01
    “…The selective index indicated that SKM13-2HCl showed the same effectiveness with SKM13 in Plasmodium falciparum in in-vitro. Even though, in vivo mouse study demonstrated that SKM13 (20 mg/kg) at single dose could not completely inhibit P. berghei growth in blood. …”
    Get full text
    Article
  9. 15189
  10. 15190
  11. 15191

    BIRC6 modifies risk of invasive bacterial infection in Kenyan children by James J Gilchrist, Silvia N Kariuki, James A Watson, Gavin Band, Sophie Uyoga, Carolyne M Ndila, Neema Mturi, Salim Mwarumba, Shebe Mohammed, Moses Mosobo, Kaur Alasoo, Kirk A Rockett, Alexander J Mentzer, Dominic P Kwiatkowski, Adrian VS Hill, Kathryn Maitland, J Anthony G Scott, Thomas N Williams

    Published 2022-07-01
    “…Here, we utilise probabilistic diagnostic models to identify children with a high probability of invasive bacterial disease among critically unwell Kenyan children with Plasmodium falciparum parasitaemia. We construct a joint dataset including 1445 bacteraemia cases and 1143 severe malaria cases, and population controls, among critically unwell Kenyan children that have previously been genotyped for human genetic variation. …”
    Get full text
    Article
  12. 15192

    Improving the efficiency of reactive case detection for malaria elimination in southern Zambia: a cross-sectional study by Fiona R. P. Bhondoekhan, Kelly M. Searle, Harry Hamapumbu, Mukuma Lubinda, Japhet Matoba, Michael Musonda, Ben Katowa, Timothy M. Shields, Tamaki Kobayashi, Douglas E. Norris, Frank C. Curriero, Jennifer C. Stevenson, Philip E. Thuma, William J. Moss, for the Southern and Central Africa International Centers of Excellence for Malaria Research

    Published 2020-05-01
    “…Methods Between January 12, 2015 and July 26, 2017, 4170 individuals residing in 158 index and 531 secondary households were enrolled and completed a baseline questionnaire in the catchment area of Macha Hospital in Choma District, Southern Province, Zambia. Plasmodium falciparum prevalence was measured using PfHRP2 RDTs and quantitative PCR (qPCR). …”
    Get full text
    Article
  13. 15193
  14. 15194
  15. 15195
  16. 15196

    Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa by Shehu S. Awandu, Jaishree Raman, Takalani I. Makhanthisa, Philip Kruger, John Frean, Teun Bousema, Jandeli Niemand, Lyn-Marie Birkholtz

    Published 2018-03-01
    “…Abstract Background Primaquine (PQ) is recommended as an addition to standard malaria treatments in pre-elimination settings due to its pronounced activity against mature Plasmodium falciparum gametocytes, the parasite stage responsible for onward transmission to mosquitoes. …”
    Get full text
    Article
  17. 15197

    Impact of Mothers’ Schistosomiasis Status During Gestation on Children’s IgG Antibody Responses to Routine Vaccines 2 Years Later and Anti-Schistosome and Anti-Malarial Responses b... by Bartholomew N. Ondigo, Bartholomew N. Ondigo, Erick M. O. Muok, John K. Oguso, Sammy M. Njenga, Henry M. Kanyi, Eric M. Ndombi, Eric M. Ndombi, Jeffrey W. Priest, Nupur Kittur, William Evan Secor, Diana M. S. Karanja, Daniel G. Colley, Daniel G. Colley

    Published 2018-06-01
    “…To provide additional data to these discussions, we have enrolled 99 close-to-term pregnant women in western Kenya and determined their Schistosoma mansoni and Plasmodium falciparum infection status. At 2 years of age, when the initial immunization schedule was complete, we determined their children’s IgG antibody levels to tetanus toxoid, diphtheria toxoid, and measles nucleoprotein (N-protein) antigens using a multiplex assay. …”
    Get full text
    Article
  18. 15198

    Seasonal Malaria Chemoprevention Therapy in Children Up To 9 Years of Age: Protocol for a Cluster-Randomized Trial Study by Mahamoudou Toure, Jeffrey G Shaffer, Daouda Sanogo, Soumba Keita, Moussa Keita, Fousseyni Kane, Bourama Traore, Djeneba Dabitao, Aissata Kone, Cheick Oumar Doumbia, Joseph Keating, Joshua Yukich, Helle H Hansson, Alyssa E Barry, Mahamadou Diakité, Michael Alifrangis, Seydou Doumbia

    Published 2024-01-01
    “…ObjectiveThe primary goal of the study is to compare 2 SMC regimens (SP-AQ and dihydroartemisinin-piperaquine [DHA-PQ]) in preventing uncomplicated Plasmodium falciparum malaria in children 3 months to 9 years old. …”
    Get full text
    Article
  19. 15199

    Design, synthesis, and biological evaluation of multiple targeting antimalarials by Yiqing Yang, Tongke Tang, Xiaolu Li, Thomas Michel, Liqin Ling, Zhenghui Huang, Maruthi Mulaka, Yue Wu, Hongying Gao, Liguo Wang, Jing Zhou, Brigitte Meunier, Hangjun Ke, Lubin Jiang, Yu Rao

    Published 2021-09-01
    “…Here, we performed a structure-based drug design on mitochondrial respiratory chain of Plasmodium falciparum and identified an extremely potent molecule, RYL-581, which binds to multiple protein binding sites of P. falciparum simultaneously (allosteric site of type II NADH dehydrogenase, Qo and Qi sites of cytochrome bc1). …”
    Get full text
    Article
  20. 15200

    Antiplasmodial, Trypanocidal, and Genotoxicity <i>In Vitro</i> Assessment of New Hybrid α,α-Difluorophenylacetamide-statin Derivatives by Carlos Fernando Araujo-Lima, Rita de Cassia Castro Carvalho, Sandra Loureiro Rosario, Debora Inacio Leite, Anna Caroline Campos Aguiar, Lizandra Vitoria de Souza Santos, Julianna Siciliano de Araujo, Kelly Salomão, Carlos Roland Kaiser, Antoniana Ursine Krettli, Monica Macedo Bastos, Claudia Alessandra Fortes Aiub, Maria de Nazaré Correia Soeiro, Nubia Boechat, Israel Felzenszwalb

    Published 2023-05-01
    “…Methods: Considering the anti-inflammatory activity of phenylacetamides and the potential microbicidal action of statins against obligate intracellular parasites, the objective of this work was to synthesize eight new hybrid compounds of α,α-difluorophenylacetamides with the moiety of statins and assess their phenotypic activity against <i>in vitro</i> models of <i>Plasmodium falciparum</i> and <i>Trypanosoma cruzi</i> infection besides exploring their genotoxicity safety profile. …”
    Get full text
    Article